Expression of Concern: Comparative efficacy of different antihypertensive drug classes for stroke prevention: A network meta-analysis of randomized controlled trials
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBlood Pressure and Hypertension Studies · Renin-Angiotensin System Studies · Phosphodiesterase function and regulation
After this article [1] was published, concerns were noted that the articles cited as References 19 and 29 respectively were retracted before [1] was published.
In addition, the PLOS One Editors have concerns about the article’s compliance with the PLOS Authorship policy.
In light of the cumulative issues, the PLOS One Editors issue this Expression of Concern. Readers are advised to interpret the article [1] with caution.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Yu D, Li J-X, Cheng Y, Wang H-D, Ma X, Ding T, et al. Comparative efficacy of different antihypertensive drug classes for stroke prevention: A network meta-analysis of randomized controlled trials. P Lo S One. 2025;20(2):e 0313309. doi: 10.1371/journal.pone.0313309 39982885 PMC 11845040 · doi ↗ · pubmed ↗